By Professor Dedee Frances Murrell

Journal articles

Sebaratnam DF; Hanna AM; Chee SN; Frew JW; Venugopal SS; Daniel BS; Martin LK; Rhodes LM; Tan JCK; Wang CQ; Welsh B; Nijsten T; Murrell DF, 2013, 'Development of a quality-of-life instrument for autoimmune bullous disease: The autoimmune bullous disease quality of life questionnaire', JAMA Dermatology, 149, pp. 1186 - 1191, http://dx.doi.org/10.1001/jamadermatol.2013.4972

Shumack S; Spelman L; Murrell DF; See J-A; Hewitt D; Foley P; Wulf HC; Bosc C; Kerrouche N; Rubel DM, 2013, 'Daylight PDT: A Convenient, Similarly Effective, and Nearly Painless Alternative to Conventional PDT', JOURNAL DER DEUTSCHEN DERMATOLOGISCHEN GESELLSCHAFT, 11, pp. 87 - 87, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000323227600269&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Kim J; Loh CH; Murrell DF, 2013, 'Epidermolysis bullosa pruriginosa triggered by scabies infestation', Journal of Dermatology, 40, pp. 562 - 563, http://dx.doi.org/10.1111/1346-8138.12167

Sekulic A; Migden MR; Basset-Seguin N; Garbe C; Gesierich A; Lao CD; Miller C; Mortier L; Murrell DF; Hamid O; Quevedo F; Schadendorf D; Hou J; Yue H, 2013, 'Long-term safety and efficacy of vismodegib in patients with advanced basal cell carcinoma (aBCC): 18-month update of the pivotal ERIVANCE BCC study.', Journal of Clinical Oncology, 31, pp. 9037 - 9037, http://dx.doi.org/10.1200/jco.2013.31.15_suppl.9037

Frew JW; Cepeda-Valdes R; Fortuna G; Salas-Alanis JC; Murrell DF, 2013, 'Cross cultural adaptation of the 'Quality of Life in Epidermolysis Bullosa' (QOLEB) questionnaire: Validation and results of a Hispanic translation', AUSTRALASIAN JOURNAL OF DERMATOLOGY, 54, pp. 39 - 40, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000319131900121&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Loh CCH; Kim J; Su JC; Daniel BS; Venugopal SS; Rhodes LM; Intong LRA; Law M; Murrell DF, 2013, 'Development, reliability and validity of a novel severity score for epidermolysis bullosa: The Epidermolysis Bullosa Disease Activity and Scarring Index (EBDASI)', AUSTRALASIAN JOURNAL OF DERMATOLOGY, 54, pp. 47 - 47, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000319131900139&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Davey JR; Fergie B; Hwang SJ; Rhodes LM; Daniel BS; Ho SJ; Mangos G; Murrell DF, 2013, 'Epidemiology of renal impairment in the Australian epidermolysis bullosa population', AUSTRALASIAN JOURNAL OF DERMATOLOGY, 54, pp. 38 - 39, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000319131900118&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Hwang SJ; Davey JR; Fergie B; Rhodes LM; Daniel BS; Murrell DF, 2013, 'Prevalence and characterisation of anaemia in patients with epidermolysis bullosa registered in Australia', AUSTRALASIAN JOURNAL OF DERMATOLOGY, 54, pp. 42 - 42, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000319131900128&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Morcos Y; Murrell DF, 2013, 'Review of cutaneous outcomes of immunomodulatory drugs for multiple sclerosis', AUSTRALASIAN JOURNAL OF DERMATOLOGY, 54, pp. 49 - 50, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000319131900146&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Daniel BS; Murrell DF, 2013, 'Complete resolution of chronic multiple verruca vulgaris treated with quadrivalent human papillomavirus vaccine', JAMA Dermatology, 149, pp. 370 - 372, http://dx.doi.org/10.1001/jamadermatol.2013.1463

Venugopal SS; Yan W; Frew JW; Cohn HI; Rhodes LM; Tran K; Melbourne W; Nelson JA; Sturm M; Fogarty J; Marinkovich MP; Igawa S; Ishida-Yamamoto A; Murrell DF, 2013, 'A phase II randomized vehicle-controlled trial of intradermal allogeneic fibroblasts for recessive dystrophic epidermolysis bullosa', Journal of the American Academy of Dermatology, 69, http://dx.doi.org/10.1016/j.jaad.2013.08.014

Daniel BS; Murrell DF; Borradori L, 2013, 'Bullous pemphigoid: Therapeutic algorithm and practical management', Expert Opinion on Orphan Drugs, 1, pp. 405 - 412, http://dx.doi.org/10.1517/21678707.2013.794693

Ramirez MN; Murrell DF; Fine JD, 2013, 'Management of epidermolysis bullosa', Expert Opinion on Orphan Drugs, 1, pp. 279 - 293, http://dx.doi.org/10.1517/21678707.2013.774274

Frew JW; Cepeda Valdes R; Fortuna G; Murrell DF; Salas Alanis J, 2013, 'Measuring quality of life in epidermolysis bullosa in Mexico: Cross-cultural validation of the Hispanic version of the Quality of Life in Epidermolysis Bullosa questionnaire', Journal of the American Academy of Dermatology, 69, pp. 652 - 653, http://dx.doi.org/10.1016/j.jaad.2013.04.053

Kim J; Teye K; Koga H; Yeoh SC; Wakefield D; Hashimoto T; Murrell DF, 2013, 'Successful single-cycle rituximab treatment in a patient with pemphigus vulgaris and squamous cell carcinoma of the tongue and IgG antibodies to desmocollins', Journal of the American Academy of Dermatology, 69, http://dx.doi.org/10.1016/j.jaad.2012.12.967

Kim M; Li M; Intong LRA; Tran K; Melbourne W; Marucci D; Bucci J; De Souza P; Mallesara G; Murrell DF, 2013, 'Use of cetuximab as an adjuvant agent to radiotherapy and surgery in recessive dystrophic epidermolysis bullosa with squamous cell carcinoma', British Journal of Dermatology, 169, pp. 208 - 210, http://dx.doi.org/10.1111/bjd.12272

Sebaratnam DF; Venugopal SS; Frew JW; McMillan J; Finkelstein ER; Martin L; Murrell DF, 2013, 'Diffuse melanosis cutis: A systematic review of the literature', Journal of the American Academy of Dermatology, 68, pp. 482 - 488, http://dx.doi.org/10.1016/j.jaad.2012.08.018

Sekulic A; Migden MR; Seguin NB; Garbe C; Gesierich A; Lao C; Miller C; Mortier L; Murrell DF; Omid H; Quevedo JF; Hou J; Yue H; Schadendorf D, 2013, 'Efficacité et tolérance à long terme du vismodegib chez des patients présentant un carcinome basocellulaire avancé (CBCa) : mise à jour à 18 mois de l’étude pivot ERIVANCE CBC', Annales de Dermatologie et de Vénéréologie, 140, pp. S392 - S393, http://dx.doi.org/10.1016/j.annder.2013.09.070

See J-A; Rubel DM; Spelman L; Murrell DF; Hewit D; Foley P; Wulf H-C; Kerob D; Shumack S, 2013, 'Efficacité et tolérance de la PDT avec Metvix® et lumière du jour dans le traitement des kératoses actiniques : une étude de phase III randomisée, controlée, en simple aveugle', Annales de Dermatologie et de Vénéréologie, 140, pp. S377 - S378, http://dx.doi.org/10.1016/j.annder.2013.09.040

Murrell DF, 2013, 'The Pitfalls of Skin Biopsies to Diagnose Epidermolysis Bullosa', Pedatric Dermatology, 30, pp. 273 - 275, http://dx.doi.org/10.1111/pde.120951525-1470

Kopecki Z; Ruzehaji N; Turner C; Iwata H; Ludwig RJ; Zillikens D; Murrell DF; Cowin AJ, 2013, 'Topically applied flightless i neutralizing antibodies improve healing of blistered skin in a murine model of epidermolysis bullosa acquisita', Journal of Investigative Dermatology, 133, pp. 1008 - 1016, http://dx.doi.org/10.1038/jid.2012.457

Daniel BS; Skowronski G; Myburgh J; Hersch M; Murrell DF, 2012, 'Concurrent Management of Toxic Epidermal Necrolysis with Thermal Water Spray and Non-Stick Dressings', Acta Dermatovenerologica Croatica, 20, pp. 210 - 212

Kopecki Z; Ruzehaji N; Turner C; Iwata H; Ludwig RJ; Zillikens D; Murrell DF; Cowin AJ, 2012, 'APPLICATION OF FLII NEUTRALIZING ANTIBODIES REDUCES THE SEVERITY OF SKIN BLISTERING IN A COLVII MODEL OF EPIDERMOLYSIS BULLOSA ACQUISITA', WOUND REPAIR AND REGENERATION, 20, pp. A60 - A60, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000308945000032&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Zane LT; Gebauer KA; Spelman L; Murrell DF; Varigos GA; Heerinckx FA; Jermano JA; Zib B; Gogoleva T, 2012, 'BORON-BASED AN2728 AND AN2898 OINTMENTS DEMONSTRATE SAFETY AND EFFICACY IN A PHASE 2A BILATERAL STUDY OF MILD-TO-MODERATE ATOPIC DERMATITIS', WOUND REPAIR AND REGENERATION, 20, pp. A69 - A69, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000308945000067&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Venugopal S; Yan W; Frew JW; Cohn HI; Tran K; Sturm M; Marinkovich P; Igawa S; Ishida-Yamamoto A; Murrell DF, 2012, 'INVESTIGATION OF CELL THERAPY FOR RECESSIVE DYSTROPHIC EPIDERMOLYSIS BULLOSA (RDEB) THROUGH INTRADERMAL INJECTION OF ALLOGENEIC FIBROBLASTS RANDOMIZED AGAINST PLACEBO INJECTIONS OF SUSPENSION SOLUTION', WOUND REPAIR AND REGENERATION, 20, pp. A68 - A68, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000308945000061&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Khan MT; Murrell DF, 2012, 'PODIATRY ASSESSMENT FOR EPIDERMOLYSIS BULLOSA', WOUND REPAIR AND REGENERATION, 20, pp. A72 - A72, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000308945000081&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Oh L; Daniel B; Murrell DF, 2012, 'REVIEW OF SIDE EFFECTS OF IMMUNOSUPPRESSIVE AGENTS USED FOR AUTOIMMUNE BLISTERING DISEASES', WOUND REPAIR AND REGENERATION, 20, pp. A76 - A76, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000308945000095&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Kim M; Li M; Intong LRA; Tran K; Melbourne W; Marucci D; Inder S; de Souza P; Mallesara G; Murrell DF, 2012, 'USE OF CETUXIMAB AS AN ADJUVANT AGENT TO RADIOTHERAPY AND SURGERY IN RECESSIVE DYSTROPHIC EPIDERMOLYSIS BULLOSA WITH SQUAMOUS CELL CARCINOMA', WOUND REPAIR AND REGENERATION, 20, pp. A60 - A60, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000308945000030&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Sebaratnam DF; Hanna A; Chee S; Frew JW; Tan JCK; Venugopal SS; Rhodes LM; Welsh B; Nijsten T; Murrell DF, 2012, 'VALIDATION OF THE PSYCHOMETRIC PROPERTIES OF A QUALITY-OF-LIFE MEASURE SPECIFIC TO AUTOIMMUNE BULLOUS DISEASE', WOUND REPAIR AND REGENERATION, 20, pp. A65 - A65, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000308945000051&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Frew JW; Murrell DF, 2012, 'Corticosteroid Use in Autoimmune Blistering Diseases', Immunology and Allergy Clinics of North America, 32, pp. 283 - 294, http://dx.doi.org/10.1016/j.iac.2012.04.008

Venugopal SS; Murrell DF, 2012, 'Diagnosis and Clinical Features of Pemphigus Vulgaris', Immunology and Allergy Clinics of North America, 32, pp. 233 - 243, http://dx.doi.org/10.1016/j.iac.2012.04.003

Daniel BS; Murrell DF; Joly P, 2012, 'Rituximab and its Use in Autoimmune Bullous Disorders', Immunology and Allergy Clinics of North America, 32, pp. 331 - 337, http://dx.doi.org/10.1016/j.iac.2012.04.013

Chee SN; Murrell DF, 2012, 'The Use of Intravenous Immunoglobulin in Autoimmune Bullous Diseases', Immunology and Allergy Clinics of North America, 32, pp. 323 - 330, http://dx.doi.org/10.1016/j.iac.2012.04.012

Murrell DF; Daniel BS; Joly P; Borradori L; Amagai M; Hashimoto T; Caux F; Marinovic B; Sinha AA; Hertl M; Bernard P; Sirois D; Cianchini G; Fairley JA; Jonkman M; Pandya A; Rubenstein D; Zillikens D; Payne A; Woodley D; Zambruno G; et A, 2012, 'Definitions and outcome measures for bullous pemphigoid: recommendations by an international panel of experts.', Journal of the American Academy of Dermatology, 66, pp. 479 - 485, http://dx.doi.org/10.1016/j.jaad.2011.06.032

Chow HT; Tran K; Millar EKA; Lynch J; Murrell DF, 2012, 'Diverse presentations of carcinoma erysipelatoides from a teaching hospital in australia.', Case Rep Dermatol Med, 2012, pp. 134938, http://dx.doi.org/10.1155/2012/134938

Ng YZ; Pourreyron C; Salas-Alanis J; Dayal JHS; Cepeda-valdes R; Yan W; Wright SW; Chen M; Fine J; Hogg FJ; Mcgrath J; Murrell DF; Leigh IM; Lane EB; South AP, 2012, 'Fibroblast-derived dermal matrix drives development of aggressive cutaneous squamous cell carcinoma complicating patients with recessive dystrophic epidermolysis bullosa.', Cancer Research, 72, pp. 3522 - 3534, http://dx.doi.org/10.1158/0008-5472.CAN-11-2996

Intong LR; Murrell DF, 2012, 'Inherited epidermolysis bullosa: New diagnostic criteria and classification', Clinics in Dermatology, 30, pp. 70 - 77, http://dx.doi.org/10.1016/j.clindermatol.2011.03.012

Sarig O; Bercovici S; Zoller L; Goldberg I; Indelman M; Nahum S; Sagiv N; Martinez de morentin H; Katz O; Baum S; Barzilai A; Trau H; Murrell DF; et A, 2012, 'Population-Specific Association between a Polymorphic Variant in ST18, Encoding a Pro-Apoptotic Molecule, and Pemphigus Vulgaris.', Journal of Investigative Dermatology, 132, pp. 1798 - 1805, http://dx.doi.org/10.1038/jid.2012.46

Sebaratnam DF; Frew JW; Davatchi F; Murrell DF, 2012, 'Quality-of-Life Measurement in Blistering Diseases', Dermatologic Clinics, 30, pp. 301 - 307, http://dx.doi.org/10.1016/j.det.2011.11.008

Daniel BS; Hertl M; Werth VP; Eming R; Murrell DF, 2012, 'Severity score indexes for blistering diseases', Clinics in Dermatology, 30, pp. 108 - 113, http://dx.doi.org/10.1016/j.clindermatol.2011.03.017

Schmitt J; Spuls P; Boers M; et A; Murrell DF; Al 15 E, 2012, 'Towards global consensus on outcome measures for atopic eczema research: results of the HOME II meeting.', Allergy, 67, pp. 1111 - 1117, http://dx.doi.org/10.1111/j.1398-9995.2012.02874.x

Garcia-Mendoza C; Murrell D, 2011, 'Adolescent acne', Australian Doctor, pp. 39 - 40

Garcia-Mendoza C; Murrell D, 2011, 'Treating psoriasis', Australian Doctor, pp. 37 - 38

Intong LRA; Murrell DF, 2011, 'Erythema Multiforme, Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis', , 1, pp. 1 - 8, http://dx.doi.org/10.1002/9781444345384.ch78

Murrell D; Daniel B, 2011, 'Atopic dermatitis', Australian Doctor, pp. 35 - 36

Martin L; Werth VP; Villaneuva E; Murrell DF, 2011, 'A systematic review of randomized controlled trials for pemphigus vulgaris and pemphigus foliaceus', Journal of the American Academy of Dermatology, 64, pp. 903 - 908, http://dx.doi.org/10.1016/j.jaad.2010.04.039

Murrell DF; Ryan T; Bergfeld W, 2011, 'Advancement of women in dermatology', International Journal of Dermatology, 50, pp. 593 - 600, http://dx.doi.org/10.1111/j.1365-4632.2011.05075.x

Murrell DF; Sebaratnam DF, 2011, 'Bullous Systemic Lupus Erythematosus', Dermatologic Clinics, 29, pp. 649 - 653, http://dx.doi.org/10.1016/j.det.2011.06.002

Frew J; Murrell DF, 2011, 'Corticosteroid Use in Autoimmune Blistering Diseases', Dermatologic Clinics, 29, pp. 535 - 544, http://dx.doi.org/10.1016/j.det.2011.06.004

Frew J; Murrell DF, 2011, 'Current Management Strategies in Paraneoplastic Pemphigus (Paraneoplastic Autoimmune Multiorgan Syndrome)', Dermatologic Clinics, 29, pp. 607 - 612, http://dx.doi.org/10.1016/j.det.2011.06.016

Back to profile page